Novo Nordisk's surprise bid for Metsera has set the stage for a high-stakes showdown in the obesity drug market, with Pfizer ...

The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...

Rounding up this week's slate of high school football contests including Class AAA No. 7 Herbert Hoover against Class AAAA No ...

Denmark's Novo Nordisk said on Thursday it has made an unsolicited bid for U.S. drug maker Metsera , after Pfizer in ...

A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to ...

Denmark's Novo Nordisk launched a rival bid for U. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer ...

Should you fill your car tyres with nitrogen instead of air? Here’s a clear, expert-backed breakdown of nitrogen tyre ...

Pfizer Inc. is threatening legal action at an attempt by Novo Nordisk A/S to scupper its acquisition of Metsera Inc., with an unsolicited $9 billion offer for the anti-obesity specialist. That trumps ...

Novo Nordisk, a leader in weight-loss drugs, is offering $6 billion up front with the potential for later milestone payments ...

Novo has proposed to acquire all outstanding shares of Metsera’s common stock at a price of $56.50 per share in cash and ...

Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; ...